Order Article Reprints

Lee M-G, Lee Y-K, Huang S-C, Chang C-L, Ko C-Y, Lee W-C, Chen T-Y, Tzou S-J, Huang C-Y, Tai M-H, et al. DLK2 Acts as a Potential Prognostic Biomarker for Clear Cell Renal Cell Carcinoma Based on Bioinformatics Analysis. Genes. 2022; 13(4):629. https://doi.org/10.3390/genes13040629

Lee, Man-Gang, Yung-Kuo Lee, Shih-Chung Huang, Chen-Lin Chang, Chou-Yuan Ko, Wen-Chin Lee, Tung-Yuan Chen, Shiow-Jyu Tzou, Cheng-Yi Huang, Ming-Hong Tai, and et al. 2022. "DLK2 Acts as a Potential Prognostic Biomarker for Clear Cell Renal Cell Carcinoma Based on Bioinformatics Analysis" Genes 13, no. 4: 629. https://doi.org/10.3390/genes13040629

Lee, M. -G., Lee, Y. -K., Huang, S. -C., Chang, C. -L., Ko, C. -Y., Lee, W. -C., Chen, T. -Y., Tzou, S. -J., Huang, C. -Y., Tai, M. -H., Lin, Y. -W., Kung, M. -L., Tsai, M. -C., Chen, Y. -L., Chang, Y. -C., Wen, Z. -H., Huang, C. -C., & Chu, T. -H. (2022). DLK2 Acts as a Potential Prognostic Biomarker for Clear Cell Renal Cell Carcinoma Based on Bioinformatics Analysis. Genes, 13(4), 629. https://doi.org/10.3390/genes13040629